New York â¢ For the first time, U.S. regulators have authorized a company to tell consumers directly about their individual genetic risk of certain diseases and conditions without involving a health care professional.
The California-based company 23andMe gained approval from the Food and Drug Administration to market genetic testing for risk of 10 ailments, including Parkinsonâs and Alzheimerâs diseases.
The FDA, which in 2013 blocked the company from providing genetic health information, announc...
Share this post
← Back to Utah